Question 33

Newborns in the U.S. are required to be tested for Phenylketonuria.

All states in the U.S. mandate testing for Phenylketonuria (PKU) in newborns as part of standard screening procedures. This condition is a metabolic disorder that can lead to intellectual disability if not detected and managed early.

A) Septicemia

Septicemia is a severe bloodstream infection that can occur in newborns, but it is not part of the standard newborn screening tests required by states. Newborn screening primarily focuses on metabolic, hormonal, and genetic disorders rather than infectious diseases like septicemia.

B) Bacteremia

Bacteremia, similar to septicemia, refers to the presence of bacteria in the bloodstream. While it is a serious condition, it is not included in the standard panel of newborn screenings mandated across the states, which are geared towards detecting genetic and metabolic disorders.

C) Phenylketonuria

Phenylketonuria (PKU) is a genetic disorder that affects the metabolism of phenylalanine, an amino acid. Newborns are routinely screened for PKU because early detection allows for dietary management that can prevent severe cognitive impairment, making it a crucial part of newborn health protocols.

D) Proteinuria

Proteinuria, which indicates the presence of excess protein in urine, is not a standard screening requirement for newborns. This condition is more relevant in the context of kidney function and disease rather than as a primary concern in newborn metabolic screenings.

Conclusion

Phenylketonuria is the only option listed that is universally required to be tested for in newborns across all U.S. states, highlighting its importance in preventing severe developmental issues. The other options, while they may relate to health concerns, do not form part of the essential newborn screening tests and fail to address the specific metabolic disorders that PKU screening aims to identify.